newsfilter
← Latest News
GlobeNewswire·

Vyant Bio Announces Investor Conference Call and Webcast for the Second Quarter and First Half of 2022

CHERRY HILL, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. ("Vyant Bio" or "Company") (NASDAQ:VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company'